DRUG

IL-6-blocking antibody

1 hypothesis across 1 therapeutic domain

ALL HYPOTHESES

Repurposing candidates for IL-6-blocking antibody

Rheumatoid arthritis 1

Mediator Outcome Score Tier Lit. status Trial
STAT3 prurigo nodularis 0.208 Mid novel signal none

Clinical trials

9 registered trials for IL-6-blocking antibody

Source: ClinicalTrials.gov